Clinical trials

  • Atezolizumab for Hepatocellular carcinoma | Intermediate-stage hepatocellular carcinoma
  • EPCORITAMAB for Diffuse large B-cell lymphoma
  • rocuronium for Postoperative residual neuromuscular blockade
  • ABEMACICLIB for Breast cancer (HR+, HER2-) | Advanced/metastatic breast cancer
  • Tirzepatide for Overweight | Obesity | Coronary artery disease
  • NAVTEMADLIN for Myelofibrosis | Primary myelofibrosis | Secondary myelofibrosis
  • ELRANATAMAB for Multiple myeloma
  • Lomustine for Glioblastoma
  • SOT201 for Advanced/metastatic solid tumors
  • Guselkumab for Psoriatic arthritis
  • ZIFTOMENIB for Acute Myeloid Leukemia|Mixed Phenotype Acute Leukemia|Acute Lymphoblastic Leukemia
  • TEZEPELUMAB for Eosinophilic esophagitis